Evidence map›Paper›PMID 33809464›Full record

ReviewPathogens (Basel, Switzerland)2021

Targeting Gametocytes of the Malaria Parasite

Jyotsna Chawla, Jenna Oberstaller, John H Adams

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Molecular mechanisms involved inFrontiers in microbiology · 2026
    Review
  3. Towards an evolutionary baseline model ofbioRxiv : the preprint server for biology · 2025
    Article
  4. Observational
  5. Recent Advances in Antimicrobial Research.Current topics in medicinal chemistry · 2025
    Article
  6. Overexpression inFrontiers in cellular and infection microbiology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Monitoring the density of3 Biotech · 2023
    Article
  11. Article
  12. Biology and epidemiology ofParasite epidemiology and control · 2023
    Review
  13. Article
  14. Targeting theHeliyon · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Identification of Novel Malaria Transmission-Blocking Vaccine Candidates.Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jyotsna ChawlaMolecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B Downs Blvd, MDC 7, Tampa, FL 33612, USA.
Jenna OberstallerCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, 3720 Spectrum Blvd, Suite 404, Tampa, FL 33612, USA.
John H AdamsCenter for Global Health and Infectious Diseases Research and USF Genomics Program, College of Public Health, University of South Florida, 3720 Spectrum Blvd, Suite 404, Tampa, FL 33612, USA.ORCID 0000-0003-3707-7979
University of South Florida · US

Funding

Chemogenomic Profiling of Plasmodium Falciparum Responses and ResistanceR01AI117017 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI ADAMS, JOHN H · 2015 to 2025
$6.9M
Discovering the essential genome of Plasmodium falciparumR01AI130171 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI ADAMS, JOHN H · 2018 to 2021
$2.8M
National Institute of Allergy and Infectious Diseases R01AI130171NIAID NIH HHS R01 AI117017NIAID NIH HHS R01 AI130171
6 · The paper itself

Abstract

Mosquito transmission of the deadly malaria parasite

Indexed as

forward genetic screensgametocyte biologysexual stagestransmission-blocking candidates

Identifiers

PMID33809464
PMCPMC7999360
OpenAlexW3138453309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.